Handelsbanken Fonder AB - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q2 2024$1,837
-0.9%
13,467
+9.8%
0.01%0.0%
Q1 2024$1,854
+29.5%
12,267
+7.9%
0.01%
+14.3%
Q4 2023$1,432
+34.6%
11,3670.0%0.01%
+16.7%
Q3 2023$1,064
+32.5%
11,367
+26.3%
0.01%
+50.0%
Q2 2023$803
-11.9%
9,000
+5.9%
0.00%
-20.0%
Q1 2023$911
+5.1%
8,500
+19.7%
0.01%0.0%
Q4 2022$867
-99.9%
7,100
-26.0%
0.01%
-28.6%
Q3 2022$991,000
+11.1%
9,6000.0%0.01%
+16.7%
Q2 2022$892,000
-21.6%
9,600
-1.0%
0.01%0.0%
Q1 2022$1,138,000
-12.8%
9,7000.0%0.01%0.0%
Q4 2021$1,305,000
-22.8%
9,700
-8.5%
0.01%
-33.3%
Q3 2021$1,690,000
+38.2%
10,600
+14.0%
0.01%
+50.0%
Q2 2021$1,223,000
+2.0%
9,3000.0%0.01%
-14.3%
Q1 2021$1,199,000
-30.2%
9,300
-9.7%
0.01%
-30.0%
Q4 2020$1,718,000
+27.9%
10,300
+18.4%
0.01%0.0%
Q3 2020$1,343,000
-47.8%
8,700
-50.0%
0.01%
-9.1%
Q2 2020$2,574,00017,4000.01%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q1 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 2,003,147$225,574,00020.44%
RA Capital Management 4,914,955$553,473,00017.48%
Sofinnova Investments, Inc. 1,109,874$124,983,00011.56%
Eversept Partners, LP 275,494$31,023,3797.71%
Avoro Capital Advisors LLC 1,787,000$201,234,0006.79%
Orbimed Advisors 3,287,400$370,194,0006.22%
Eventide Asset Management 1,698,648$191,285,0006.19%
Logos Global Management LP 120,000$13,513,0005.14%
Ghost Tree Capital, LLC 150,000$16,892,0004.48%
Spyglass Capital Management LLC 351,388$39,570,0004.47%
View complete list of ASCENDIS PHARMA A/S shareholders